Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study

Title
Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 125, Issue 5, Pages 1143-1146
Publisher
Wiley
Online
2009-03-12
DOI
10.1002/ijc.24423

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started